One company's success demonstrates that there's hope for building truly integrated worldwide communications teams.
With one extraordinary product, Novartis showed how to make the most of relationships with patient advocacy groups.
Publicizing clinical trial results can backfire if companies fail to ask themselves the tough questions.
Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial